ICON Management

Management criteria checks 3/4

ICON's CEO is Barry Balfe, appointed in Oct 2025, has a tenure of less than a year. total yearly compensation is $3.29M, comprised of 25.9% salary and 74.1% bonuses, including company stock and options. directly owns 0.006% of the company’s shares, worth €587.71K. The average tenure of the management team and the board of directors is 3.6 years and 5.9 years respectively.

Key information

Barry Balfe

Chief executive officer

US$3.3m

Total compensation

CEO salary percentage	25.90%
CEO tenure	less than a year
CEO ownership	0.006%
Management average tenure	3.6yrs
Board average tenure	5.9yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Barry Balfe's remuneration changed compared to ICON's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2025	US$3m	US$851k	US$229m

Compensation vs Market: Barry's total compensation ($USD3.29M) is below average for companies of similar size in the German market ($USD5.53M).

Compensation vs Earnings: Insufficient data to compare Barry's compensation with company performance.

CEO

Barry Balfe (47 yo)

less than a year

Tenure

US$3,286,000

Compensation

Mr. Barry Balfe serves as Chief Executive Officer and Director at ICON Public Limited Company since October 1, 2025. He served as President of ICON Pharma Solutions at ICON Public Limited Company since 202...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Barry Balfe	CEO & Director	less than a year	US$3.29m	0.0058% € 587.7k
John Climax	Founder & Independent Non-Executive Director	no data	US$320.00k	0.38% € 37.9m
Nigel Clerkin	Chief Financial Officer	1.7yrs	US$2.09m	0.0050% € 507.9k
Steve Empoliti	Chief Commercial Officer	1.4yrs	US$19.96m	no data
Lyons Emer	Chief Accounting Officer	no data	no data	0.00098% € 99.0k
Thomas O'Leary	Chief Information Officer	no data	no data	no data
Diarmaid Cunningham	Chief Administrative Officer	16.6yrs	no data	no data
Niamh Murphy	Director of Corporate Communications	no data	no data	no data
David Green	Vice President of Marketing	no data	no data	no data
Joe Cronin	Chief Human Resources Officer	9.9yrs	no data	no data
Simon Holmes	President of Corporate Investments & Partnerships	3.6yrs	no data	no data
Gary Curtis	Senior Vice President of Global Clinical Pharmacology	17.2yrs	no data	no data

3.6yrs

Average Tenure

52yo

Average Age

Experienced Management: IJF's management team is considered experienced (3.6 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Barry Balfe	CEO & Director	less than a year	US$3.29m	0.0058% € 587.7k
John Climax	Founder & Independent Non-Executive Director	16.4yrs	US$320.00k	0.38% € 37.9m
Linda Grais	Independent Director	4.9yrs	US$353.00k	0.0069% € 694.8k
Eugene McCague	Independent Non-Executive Director	8.7yrs	US$353.00k	0.0038% € 384.7k
Ciaran Murray	Independent Non-Executive Chairman of the Board	14.7yrs	US$710.00k	0.027% € 2.7m
Jeffrey Elliott	Director	no data	no data	no data
Ronan Murphy	Lead Independent Director	9.7yrs	US$398.00k	0.0039% € 389.8k
Anne Michelle Whitaker	Independent Non-Executive Director	1.9yrs	US$248.00k	no data
Julie O'Neill	Independent Non-Executive Director	6.9yrs	US$345.00k	0.0035% € 355.5k
Kevin Egan	Director	no data	no data	no data

5.9yrs

Average Tenure

61.5yo

Average Age

Experienced Board: IJF's board of directors are considered experienced (5.9 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/09 08:20
End of Day Share Price	2026/06/09 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ICON Public Limited Company is covered by 30 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Eric Coldwell	Baird
Luke Sergott	Barclays
Douglas Tsao	Barclays